Profile data is unavailable for this security.
About the company
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. It is leveraging its RAP Platform to advance a pipeline of programs initially focused on metabolic and central nervous system (CNS) disorders with validated disease biology and potential market opportunities due to the significant unmet need of affected patients. Its lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the treatment of urea cycle disorders. CMP-CPS-001 is designed to improve urea cycle activity by amplifying expression of CPS1, a key enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. Its CNS development program, CMP-SYNGAP, is focused on addressing the underlying cause of SYNGAP1-related disorders.
- Revenue in USD (TTM)350.00k
- Net income in USD-49.71m
- Incorporated2015
- Employees58.00
- LocationCAMP4 Therapeutics CorpOne Kendall SquareBldg 1400 West 3rd FloorCAMBRIDGE 02139United StatesUSA
- Phone+1 (617) 651-8867
- Fax+1 (302) 655-5049
- Websitehttps://www.camp4tx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | 0.00 | -6.47m | 104.03m | 10.00 | -- | 14.05 | -- | -- | -1.99 | -1.99 | 0.00 | 1.40 | 0.00 | -- | -- | 0.00 | -88.32 | -54.07 | -112.04 | -60.60 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -- | -- |
| Inovio Pharmaceuticals Inc | 203.41k | -112.88m | 105.41m | 122.00 | -- | 1.44 | -- | 518.24 | -4.49 | -4.49 | 0.008 | 2.82 | 0.0014 | -- | 0.2184 | 1,667.30 | -75.21 | -59.52 | -96.91 | -71.29 | -- | -- | -55,491.91 | -4,097.36 | -- | -- | 0.00 | -- | -91.89 | -51.33 | 51.71 | -- | -31.22 | -- |
| Century Therapeutics Inc | 2.69m | -129.89m | 105.44m | 152.00 | -- | 0.5358 | -- | 39.27 | -1.86 | -1.86 | 0.0372 | 2.31 | 0.0068 | -- | -- | 17,664.47 | -33.04 | -- | -34.83 | -- | -- | -- | -4,837.73 | -- | -- | -- | 0.00 | -- | -57.01 | -- | -4.38 | -- | -- | -- |
| INmune Bio Inc | 42.00k | -41.27m | 105.54m | 11.00 | -- | 2.73 | -- | 2,512.88 | -2.18 | -2.18 | 0.0022 | 1.74 | 0.0007 | -- | 0.0228 | 3,818.18 | -71.48 | -37.82 | -94.55 | -41.86 | -- | -- | -98,266.66 | -14,901.03 | -- | -34.08 | 0.0606 | -- | -58.56 | -- | -9.92 | -- | -- | -- |
| Tiziana Life Sciences Ltd - ADR | 0.00 | -17.69m | 107.34m | 9.00 | -- | 18.06 | -- | -- | -0.1726 | -0.1726 | 0.00 | 0.0537 | 0.00 | -- | -- | 0.00 | -91.52 | -58.16 | -138.98 | -75.36 | -- | -- | -- | -- | -- | -- | 0.0427 | -- | -- | -- | -14.90 | -- | -- | -- |
| Rani Therapeutics Holdings Inc | 0.00 | -28.17m | 109.36m | 140.00 | -- | 35.26 | -- | -- | -1.06 | -1.06 | 0.00 | 0.0579 | 0.00 | -- | -- | 0.00 | -96.37 | -- | -165.17 | -- | -- | -- | -- | -- | -- | -16.57 | 0.8306 | -- | -- | -- | -11.06 | -- | -- | -- |
| Alto Neuroscience Inc | 0.00 | -57.45m | 110.26m | 88.00 | -- | 0.6683 | -- | -- | -2.42 | -2.42 | 0.00 | 6.12 | 0.00 | -- | -- | 0.00 | -46.93 | -- | -51.10 | -- | -- | -- | -- | -- | -- | -- | 0.0649 | -- | -- | -- | -31.02 | -- | -- | -- |
| Context Therapeutics Inc | 0.00 | -30.15m | 112.50m | 5.00 | -- | 1.34 | -- | -- | -0.9117 | -0.9117 | 0.00 | 1.12 | 0.00 | -- | -- | 0.00 | -55.16 | -- | -58.90 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
| CAMP4 Therapeutics Corp | 350.00k | -49.71m | 112.74m | 58.00 | -- | -- | -- | 322.11 | -2.55 | -2.55 | 0.0179 | 0.7707 | -- | -- | -- | 5,468.75 | -- | -- | -- | -- | -- | -- | -14,203.71 | -- | -- | -- | 0.0221 | -- | -- | -- | -11.54 | -- | -- | -- |
| Lineage Cell Therapeutics Inc | 8.72m | -20.11m | 113.30m | 75.00 | -- | 1.71 | -- | 12.99 | -0.1096 | -0.1096 | 0.0474 | 0.3505 | 0.086 | -- | 20.83 | 116,253.30 | -19.77 | -19.53 | -22.80 | -22.59 | 95.00 | 89.13 | -229.91 | -370.88 | -- | -- | 0.0021 | -- | -39.16 | 12.39 | 18.22 | -- | -27.16 | -- |
| Invizyne Technologies Inc | 0.00 | -5.12m | 117.85m | 31.00 | -- | -- | -- | -- | -0.6305 | -0.6305 | 0.00 | -0.4431 | 0.00 | -- | -- | 0.00 | -146.70 | -- | -- | -- | -- | -- | -- | -- | -- | -66.29 | -- | -- | -- | -- | -46.00 | -- | -- | -- |
| Adverum Biotechnologies Inc | 1.00m | -94.11m | 119.61m | 121.00 | -- | 0.8299 | -- | 119.61 | -6.03 | -6.03 | 0.0585 | 6.93 | 0.0046 | -- | -- | 8,264.46 | -43.66 | -36.39 | -50.24 | -39.04 | -- | -- | -9,411.10 | -5,279.60 | -- | -- | 0.00 | -- | -- | 17.43 | 24.18 | -- | -0.0247 | -- |
| Outlook Therapeutics Inc | 0.00 | -94.05m | 121.35m | 24.00 | -- | -- | -- | -- | -8.12 | -8.12 | 0.00 | -3.57 | 0.00 | -- | -- | 0.00 | -205.48 | -214.69 | -- | -1,843.48 | -- | -- | -- | -3,043.92 | -- | -26.89 | -- | -- | -- | -- | 10.70 | -- | -- | -- |
| Ventyx Biosciences Inc | 0.00 | -152.52m | 122.33m | 75.00 | -- | 0.4386 | -- | -- | -2.37 | -2.37 | 0.00 | 3.94 | 0.00 | -- | -- | 0.00 | -48.98 | -- | -52.21 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -77.97 | -- | -- | -- |
| Vigil Neuroscience Inc | 0.00 | -82.60m | 122.64m | 66.00 | -- | 1.34 | -- | -- | -2.07 | -2.07 | 0.00 | 2.23 | 0.00 | -- | -- | 0.00 | -56.88 | -- | -66.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.98 | -- | -- | -- |
